Actively Recruiting

Phase Not Applicable
Age: 12Years +
All Genders
NCT05941052

Assessing Diagnostics At Point-of-care for Tuberculosis

Led by University of California, San Francisco · Updated on 2026-03-09

1350

Participants Needed

3

Research Sites

265 weeks

Total Duration

On this page

Sponsors

U

University of California, San Francisco

Lead Sponsor

U

University Hospital Heidelberg

Collaborating Sponsor

AI-Summary

What this Trial Is About

Every year, more than 3 million people with TB remain undiagnosed and 1 million die. Better diagnostics are essential to reducing the enormous burden of TB worldwide. The Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT) study seeks to reduce the burden of TB worldwide by evaluating faster, simpler, and less expensive TB triage and diagnostic tests.

CONDITIONS

Official Title

Assessing Diagnostics At Point-of-care for Tuberculosis

Who Can Participate

Age: 12Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Non-hospitalized adults aged 12 years or older
  • Have a cough lasting at least 2 weeks, OR have TB risk factors plus a positive TB screening
  • TB risk factors include HIV infection, close contact with TB, or history of mining work
  • Positive TB screening for people living with HIV requires C Reactive Protein greater than 5 mg/dL or abnormal chest X-ray
  • Positive TB screening for close contacts or miners requires an abnormal chest X-ray
  • Health workers aged 18 years or older involved in routine TB testing
Not Eligible

You will not qualify if you...

  • Completed latent or active TB treatment within the past 12 months
  • Taken any anti-mycobacterial medication, including fluoroquinolones, within 2 weeks before study entry
  • Reside more than 20 km from the study site or unwilling to return for follow-up visits
  • Unwilling to provide informed consent
  • Health workers unwilling to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Zankli Research Center, Bingham University

Abuja, Nigeria

Actively Recruiting

2

De La Salle Medical and Health Sciences Institute

Dasmariñas, Philippines

Actively Recruiting

3

Centre for Infectious Disease Research in Zambia

Lusaka, Zambia

Actively Recruiting

Loading map...

Research Team

A

Adithya Cattamanchi

CONTACT

C

Catherine Cook

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here